Repligen | RGEN - 利息收入

股票价格

116.35

每天变化

2.47 2.17%

每月一次

-13.60%

每年

-19.84%

Q1 预测

110.46

金融业

USD

USD 2.95B

现金及等价物

USD 566.02M

USD 94.08M

USD 1.14B

USD 135.83M

USD 542.21M

USD 19.97M

USD 39.54M

1.78K

EPS每股收益

USD 0.49

股本和储备

USD 2.11B

USD 103.83M

债务利息支出

USD 5.5M

USD 7.31M

USD 542.21M

USD 6.35B

USD 13.29M

USD 177.95M

USD 19.97M

普通股股本

USD 56.33M

164.06

USD 17.11M

USD 197.91M

销售和管理费用

USD 74.36M

USD 170.46M

贸易债权人

USD 30.01M

应收帐款人

USD 158.59M

	利息收入	更改		日
Agilent	USD 17M		1000K	2025-09
Align Technology	USD 3.25M		390K	2025-09
Bio Techne	USD 971K		386K	2025-09
BioMarin Pharmaceutical	USD 17.85M		973K	2025-09
Bruker	USD 4.4M		1.5M	2025-09
Charles River Laboratories	USD 1.1		1.1M	2025-09
Danaher	USD 1.27		8M	2025-09
Dentsply International	USD 4M		1000K	2025-03
Exact Sciences	USD -5.29		5.08	2024-12
General Electric Aerospace	USD 162M		2M	2025-09
Henry Schein	USD 0.84		9M	2025-09
Illumina	USD 0.98		10M	2025-09
IQVIA Holdings	USD 13M		3M	2025-09
Myriad Genetics	USD 300K		0	2025-03
Pfizer	USD 0.62		156M	2025-09
Repligen	USD 7.31M		979K	2025-03
Revvity	USD 0.4		8.34M	2025-09
Standard Biotools	USD 2.14M		321K	2025-09
Thermo Fisher Scientific	USD 4.27		297M	2025-09
Waters	USD 2.5		4.51M	2025-09
West Pharmaceutical Services	USD 4.7M		1.1M	2025-09